Skip to main content
OpenTrials
Completed

NCT Number: NCT06077188

EFFECT of CHEWING GUM on CONTROLLING NAUSEA/VOMITING and THIRST in PATIENTS with ACUTE PANCREATITIS

Nausea and vomiting are one of the most common symptoms in acute pancreatitis. In addition to pharmacological methods for nausea and vomiting, non-pharmacological methods can also be used. Among these, anticipatory nausea and vomiting can be prevented by behaviors aimed at distracting attention. This study will be conducted to evaluate the effect of chewing gum on the severity of nausea-vomiting and thirst in patients with acute pancreatitis. The study will be conducted with a total of 60 patients, 30 intervention and 30 control.

Patients in the intervention group will chew xylitol gum five times a day for three days. The patients' thirst and nausea and vomiting conditions will be examined.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Acute Pancreatitis Digestive System Diseases Pancreatic Diseases Pancreatitis Pathological Conditions, Signs and Symptoms Signs and Symptoms Signs and Symptoms, Digestive Thirst Vomiting

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Erciyes University Hospital

Kayseri, 38039, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Those diagnosed with acute pancreatitis,
  • Without total dental prosthesis,
  • Without salivary gland infection,
  • Those who have not had salivary gland surgery,
  • No difficulty in chewing,
  • Not receiving oxygen therapy,
  • Able to answer all questions and be communicativ

Exclusion criteria

  • Those with diabetes,
  • Does not like chewing gum,
  • Receiving radiotherapy or chemotherapy,

Treatment and study plan

Gum group

Other

Group chewing gum with xylitol

Primary outcomes

  1. Thirst Severity -Visual Analog Scale

    Time frame: Apply in the morning of the 1st day after application

    Visual Analog Scale is a 10 cm long scale that evaluates the severity of thirst.

Secondary outcomes

  1. Rhodes Nausea, Vomiting and Retching Index

    Time frame: Apply in the morning of the 1st day after application

    It is an eight-item scale that measures the number and severity of patients' nausea, vomiting and retching in the last 24 hours.

  2. Rhodes Nausea, Vomiting and Retching Index (

    Time frame: Apply in the morning of the 1st day after application

    It is an eight-item scale that measures the number and severity of patients' nausea, vomiting and retching in the last 24 hours.

Sponsors and collaborators

Lead sponsor

TC Erciyes University

Other

Registry information

Official study title

Erciyes University

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Oct 11, 2023
Registry last updated
Mar 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.